{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T14:30:02Z","timestamp":1742913002012,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":53,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071637692"},{"type":"electronic","value":"9781071637708"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3770-8_4","type":"book-chapter","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T09:45:38Z","timestamp":1717062338000},"page":"89-133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["New Generation Self-Replicating RNA Vaccines Derived from Pestivirus Genome"],"prefix":"10.1007","author":[{"given":"Thomas","family":"D\u00e9moulins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navapon","family":"Techakriengkrai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Ebensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Liniger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teerawut","family":"Nedumpun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth C.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanipa","family":"Suradhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Ruggli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399408000859","volume":"10","author":"GJ Atkins","year":"2008","unstructured":"Atkins GJ, Fleeton MN, Sheahan BJ (2008) Therapeutic and prophylactic applications of alphavirus vectors. Expert Rev Mol Med 10:e33. https:\/\/doi.org\/10.1017\/S1462399408000859","journal-title":"Expert Rev Mol Med"},{"key":"4_CR2","doi-asserted-by":"publisher","unstructured":"Blakney AK, Ip S, Geall AJ (2021) An update on self-amplifying mRNA vaccine development. Vaccines (Basel) 9(2). https:\/\/doi.org\/10.3390\/vaccines9020097","DOI":"10.3390\/vaccines9020097"},{"issue":"2","key":"4_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1586\/14760584.2015.965690","volume":"14","author":"K Ljungberg","year":"2015","unstructured":"Ljungberg K, Liljestrom P (2015) Self-replicating alphavirus RNA vaccines. Expert Rev Vaccines 14(2):177\u2013194. https:\/\/doi.org\/10.1586\/14760584.2015.965690","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"4_CR4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.4155\/tde.12.90","volume":"3","author":"KC McCullough","year":"2012","unstructured":"McCullough KC, Bassi I, Demoulins T, Thomann-Harwood LJ, Ruggli N (2012) Functional RNA delivery targeted to dendritic cells by synthetic nanoparticles. Ther Deliv 3(9):1077\u20131099","journal-title":"Ther Deliv"},{"issue":"5","key":"4_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1051\/vetres:2006028","volume":"37","author":"CF Frey","year":"2006","unstructured":"Frey CF, Bauhofer O, Ruggli N, Summerfield A, Hofmann MA, Tratschin JD (2006) Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application. Vet Res 37(5):655\u2013670. https:\/\/doi.org\/10.1051\/vetres:2006028","journal-title":"Vet Res"},{"issue":"2","key":"4_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1517\/14712598.6.2.135","volume":"6","author":"GP Pijlman","year":"2006","unstructured":"Pijlman GP, Suhrbier A, Khromykh AA (2006) Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications. Expert Opin Biol Ther 6(2):135\u2013145. https:\/\/doi.org\/10.1517\/14712598.6.2.135","journal-title":"Expert Opin Biol Ther"},{"issue":"7","key":"4_CR7","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.vaccine.2010.12.026","volume":"29","author":"R Suter","year":"2011","unstructured":"Suter R, Summerfield A, Thomann-Harwood LJ, McCullough KC, Tratschin JD, Ruggli N (2011) Immunogenic and replicative properties of classical swine fever virus replicon particles modified to induce IFN-alpha\/beta and carry foreign genes. Vaccine 29(7):1491\u20131503. https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.026","journal-title":"Vaccine"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jconrel.2017.09.018","volume":"266","author":"T D\u00e9moulins","year":"2017","unstructured":"D\u00e9moulins T, Ebensen T, Schulze K, Englezou PC, Pelliccia M, Guzman CA, Ruggli N, McCullough KC (2017) Self-replicating RNA vaccine functionality modulated by fine-tuning of polyplex delivery vehicle structure. J Control Release 266:256\u2013271. https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.018","journal-title":"J Control Release"},{"issue":"3","key":"4_CR9","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.nano.2015.11.001","volume":"12","author":"T D\u00e9moulins","year":"2016","unstructured":"D\u00e9moulins T, Milona P, Englezou PC, Ebensen T, Schulze K, Suter R, Pichon C, Midoux P, Guzman CA, Ruggli N, McCullough KC (2016) Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines. Nanomedicine 12(3):711\u2013722. https:\/\/doi.org\/10.1016\/j.nano.2015.11.001","journal-title":"Nanomedicine"},{"key":"4_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.622385","volume":"11","author":"T D\u00e9moulins","year":"2020","unstructured":"D\u00e9moulins T, Ruggli N, Gerber M, Thomann-Harwood LJ, Ebensen T, Schulze K, Guzman CA, McCullough KC (2020) Self-amplifying pestivirus replicon RNA encoding influenza virus nucleoprotein and hemagglutinin promote humoral and cellular immune responses in pigs. Front Immunol 11:622385. https:\/\/doi.org\/10.3389\/fimmu.2020.622385","journal-title":"Front Immunol"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.omtn.2018.04.019","volume":"12","author":"PC Englezou","year":"2018","unstructured":"Englezou PC, Sapet C, D\u00e9moulins T, Milona P, Ebensen T, Schulze K, Guzman CA, Poulhes F, Zelphati O, Ruggli N, McCullough KC (2018) Self-amplifying replicon RNA delivery to dendritic cells by cationic lipids. Mol Ther Nucleic Acids 12:118\u2013134","journal-title":"Mol Ther Nucleic Acids"},{"key":"4_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.24","volume":"3","author":"KC McCullough","year":"2014","unstructured":"McCullough KC, Bassi I, Milona P, Suter R, Thomann-Harwood L, Englezou P, Demoulins T, Ruggli N (2014) Self-replicating replicon-RNA delivery to dendritic cells by chitosan-nanoparticles for translation in vitro and in vivo. Mol Ther Nucleic Acids 3:e173. https:\/\/doi.org\/10.1038\/mtna.2014.24","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"4_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0034-5288(18)34087-6","volume":"13","author":"L Kasza","year":"1972","unstructured":"Kasza L, Shadduck JA, Christofinis GJ (1972) Establishment, viral susceptibility and biological characteristics of a swine kidney cell line SK-6. Res Vet Sci 13(1):46\u201351","journal-title":"Res Vet Sci"},{"key":"4_CR14","unstructured":"Tratschin JD, Ruggli N, McCullough KC (2008) Pestivirus replicons providing an RNA-based viral vector system. PCT\/EP2009\/003892 (EP2130912):WO 2009146867"},{"issue":"6","key":"4_CR15","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1128\/jvi.70.6.3478-3487.1996","volume":"70","author":"N Ruggli","year":"1996","unstructured":"Ruggli N, Tratschin JD, Mittelholzer C, Hofmann MA (1996) Nucleotide sequence of classical swine fever virus strain Alfort\/187 and transcription of infectious RNA from stably cloned full-length cDNA. J Virol 70(6):3478\u20133487","journal-title":"J Virol"},{"issue":"2","key":"4_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1128\/JVI.01509-08","volume":"83","author":"N Ruggli","year":"2009","unstructured":"Ruggli N, Summerfield A, Fiebach AR, Guzylack-Piriou L, Bauhofer O, Lamm CG, Waltersperger S, Matsuno K, Liu L, Gerber M, Choi KH, Hofmann MA, Sakoda Y, Tratschin JD (2009) Classical swine fever virus can remain virulent after specific elimination of the interferon regulatory factor 3-degrading function of Npro. J Virol 83(2):817\u2013829. https:\/\/doi.org\/10.1128\/JVI.01509-08","journal-title":"J Virol"},{"issue":"13","key":"4_CR17","doi-asserted-by":"publisher","first-page":"7645","DOI":"10.1128\/JVI.77.13.7645-7654.2003","volume":"77","author":"N Ruggli","year":"2003","unstructured":"Ruggli N, Tratschin JD, Schweizer M, McCullough KC, Hofmann MA, Summerfield A (2003) Classical swine fever virus interferes with cellular antiviral defense: evidence for a novel function of N(pro). J Virol 77(13):7645\u20137654","journal-title":"J Virol"},{"issue":"9","key":"4_CR18","doi-asserted-by":"publisher","first-page":"7787","DOI":"10.1128\/JVI.73.9.7787-7794.1999","volume":"73","author":"C Moser","year":"1999","unstructured":"Moser C, Stettler P, Tratschin JD, Hofmann MA (1999) Cytopathogenic and noncytopathogenic RNA replicons of classical swine fever virus. J Virol 73(9):7787\u20137794","journal-title":"J Virol"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.virol.2014.01.026","volume":"452-453","author":"K Gottipati","year":"2014","unstructured":"Gottipati K, Acholi S, Ruggli N, Choi KH (2014) Autocatalytic activity and substrate specificity of the pestivirus N-terminal protease Npro. Virology 452-453:303\u2013309. https:\/\/doi.org\/10.1016\/j.virol.2014.01.026","journal-title":"Virology"},{"issue":"3\u20134","key":"4_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.vaccine.2003.08.006","volume":"22","author":"D Mayer","year":"2004","unstructured":"Mayer D, Hofmann MA, Tratschin JD (2004) Attenuation of classical swine fever virus by deletion of the viral N(pro) gene. Vaccine 22(3\u20134):317\u2013328","journal-title":"Vaccine"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0065-3527(08)60348-6","volume":"53","author":"N Ruggli","year":"1999","unstructured":"Ruggli N, Rice CM (1999) Functional cDNA clones of the Flaviviridae: strategies and applications. Adv Virus Res 53:183\u2013207. https:\/\/doi.org\/10.1016\/s0065-3527(08)60348-6","journal-title":"Adv Virus Res"},{"key":"4_CR22","first-page":"321","volume":"23","author":"RJ Lorenz","year":"1973","unstructured":"Lorenz RJ, Bogel K (1973) Laboratory techniques in rabies: methods of calculation. Monogr Ser World Health Organ 23:321\u2013335","journal-title":"Monogr Ser World Health Organ"},{"issue":"32","key":"4_CR23","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1016\/j.vaccine.2011.05.026","volume":"29","author":"T Ebensen","year":"2011","unstructured":"Ebensen T, Libanova R, Schulze K, Yevsa T, Morr M, Guzman CA (2011) Bis-(3\u2032,5\u2032)-cyclic dimeric adenosine monophosphate: strong Th1\/Th2\/Th17 promoting mucosal adjuvant. Vaccine 29(32):5210\u20135220. https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.026","journal-title":"Vaccine"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jconrel.2015.03.017","volume":"206","author":"A Mittal","year":"2015","unstructured":"Mittal A, Schulze K, Ebensen T, Weissmann S, Hansen S, Guzman CA, Lehr CM (2015) Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination. J Control Release 206:140\u2013152. https:\/\/doi.org\/10.1016\/j.jconrel.2015.03.017","journal-title":"J Control Release"},{"issue":"1","key":"4_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.nano.2014.08.009","volume":"11","author":"A Mittal","year":"2015","unstructured":"Mittal A, Schulze K, Ebensen T, Weissmann S, Hansen S, Lehr CM, Guzman CA (2015) Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation. Nanomedicine 11(1):147\u2013154. https:\/\/doi.org\/10.1016\/j.nano.2014.08.009","journal-title":"Nanomedicine"},{"issue":"11\u201312","key":"4_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/hum.2021.052","volume":"32","author":"A Bisgin","year":"2021","unstructured":"Bisgin A, Sanlioglu AD, Eksi YE, Griffith TS, Sanlioglu S (2021) Current update on severe acute respiratory syndrome coronavirus 2 vaccine development with a special emphasis on gene therapy viral vector design and construction for vaccination. Hum Gene Ther 32(11\u201312):541\u2013562. https:\/\/doi.org\/10.1089\/hum.2021.052","journal-title":"Hum Gene Ther"},{"key":"4_CR27","doi-asserted-by":"publisher","unstructured":"Chandrasekar SS, Kingstad-Bakke B, Wu CW, Suresh M, Talaat AM (2020) A novel mucosal adjuvant system for immunization against avian coronavirus causing infectious bronchitis. J Virol 94(19). https:\/\/doi.org\/10.1128\/JVI.01016-20","DOI":"10.1128\/JVI.01016-20"},{"issue":"6","key":"4_CR28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","volume":"20","author":"B Pulendran","year":"2021","unstructured":"Pulendran B, Arunachalam PS, O\u2019Hagan DT (2021) Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov 20(6):454\u2013475. https:\/\/doi.org\/10.1038\/s41573-021-00163-y","journal-title":"Nat Rev Drug Discov"},{"key":"4_CR29","doi-asserted-by":"publisher","unstructured":"Yan H, Chen W (2021) The promise and challenges of cyclic dinucleotides as molecular adjuvants for vaccine development. Vaccines (Basel) 9(8). https:\/\/doi.org\/10.3390\/vaccines9080917","DOI":"10.3390\/vaccines9080917"},{"issue":"10","key":"4_CR30","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1080\/21645515.2021.1934354","volume":"17","author":"GG Guerrero Manriquez","year":"2021","unstructured":"Guerrero Manriquez GG, Tuero I (2021) Adjuvants: friends in vaccine formulations against infectious diseases. Hum Vaccin Immunother 17(10):3539\u20133550. https:\/\/doi.org\/10.1080\/21645515.2021.1934354","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"4_CR31","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1016\/j.nano.2017.08.015","volume":"13","author":"K Schulze","year":"2017","unstructured":"Schulze K, Ebensen T, Chandrudu S, Skwarczynski M, Toth I, Olive C, Guzman CA (2017) Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection. Nanomedicine 13(8):2463\u20132474. https:\/\/doi.org\/10.1016\/j.nano.2017.08.015","journal-title":"Nanomedicine"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3389\/fimmu.2017.01223","volume":"8","author":"T Ebensen","year":"2017","unstructured":"Ebensen T, Debarry J, Pedersen GK, Blazejewska P, Weissmann S, Schulze K, McCullough KC, Cox RJ, Guzman CA (2017) Mucosal administration of cycle-di-nucleotide-adjuvanted virosomes efficiently induces protection against influenza H5N1 in mice. Front Immunol 8:1223. https:\/\/doi.org\/10.3389\/fimmu.2017.01223","journal-title":"Front Immunol"},{"issue":"50","key":"4_CR33","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.1016\/j.vaccine.2017.10.072","volume":"35","author":"A Landi","year":"2017","unstructured":"Landi A, Law J, Hockman D, Logan M, Crawford K, Chen C, Kundu J, Ebensen T, Guzman CA, Deschatelets L, Krishnan L, Tyrrell DLJ, Houghton M (2017) Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes. Vaccine 35(50):6949\u20136956. https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.072","journal-title":"Vaccine"},{"key":"4_CR34","doi-asserted-by":"publisher","unstructured":"Lanfermann C, Wintgens S, Ebensen T, Kohn M, Laudeley R, Schulze K, Rheinheimer C, Hegemann JH, Guzman CA, Klos A (2021) Prophylactic multi-subunit vaccine against Chlamydia trachomatis: in vivo evaluation in mice. Vaccines (Basel) 9(6). https:\/\/doi.org\/10.3390\/vaccines9060609","DOI":"10.3390\/vaccines9060609"},{"issue":"2","key":"4_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005300","volume":"11","author":"MN Matos","year":"2017","unstructured":"Matos MN, Cazorla SI, Schulze K, Ebensen T, Guzman CA, Malchiodi EL (2017) Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi. PLoS Negl Trop Dis 11(2):e0005300. https:\/\/doi.org\/10.1371\/journal.pntd.0005300","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"4_CR36","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1096\/fj.201601093R","volume":"31","author":"C Rueckert","year":"2017","unstructured":"Rueckert C, Rand U, Roy U, Kasmapour B, Strowig T, Guzman CA (2017) Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING. FASEB J 31(7):3107\u20133115. https:\/\/doi.org\/10.1096\/fj.201601093R","journal-title":"FASEB J"},{"issue":"35","key":"4_CR37","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1016\/j.vaccine.2019.07.019","volume":"37","author":"J Volckmar","year":"2019","unstructured":"Volckmar J, Knop L, Stegemann-Koniszewski S, Schulze K, Ebensen T, Guzman CA, Bruder D (2019) The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)\/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells. Vaccine 37(35):4963\u20134974. https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.019","journal-title":"Vaccine"},{"issue":"4","key":"4_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095728","volume":"9","author":"I Skrnjug","year":"2014","unstructured":"Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman CA (2014) The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS One 9(4):e95728. https:\/\/doi.org\/10.1371\/journal.pone.0095728","journal-title":"PLoS One"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.mib.2015.12.005","volume":"30","author":"J Gao","year":"2016","unstructured":"Gao J, Tao J, Liang W, Jiang Z (2016) Cyclic (di)nucleotides: the common language shared by microbe and host. Curr Opin Microbiol 30:79\u201387. https:\/\/doi.org\/10.1016\/j.mib.2015.12.005","journal-title":"Curr Opin Microbiol"},{"key":"4_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mib.2015.12.007","volume":"30","author":"TN Huynh","year":"2016","unstructured":"Huynh TN, Woodward JJ (2016) Too much of a good thing: regulated depletion of c-di-AMP in the bacterial cytoplasm. Curr Opin Microbiol 30:22\u201329. https:\/\/doi.org\/10.1016\/j.mib.2015.12.007","journal-title":"Curr Opin Microbiol"},{"key":"4_CR41","doi-asserted-by":"publisher","unstructured":"Chelvanambi M, Fecek RJ, Taylor JL, Storkus WJ (2021) STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. J Immunother Cancer 9(2). https:\/\/doi.org\/10.1136\/jitc-2020-001906","DOI":"10.1136\/jitc-2020-001906"},{"issue":"6","key":"4_CR42","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1158\/2326-6066.CIR-16-0284","volume":"5","author":"JB Foote","year":"2017","unstructured":"Foote JB, Kok M, Leatherman JM, Armstrong TD, Marcinkowski BC, Ojalvo LS, Kanne DB, Jaffee EM, Dubensky TW Jr, Emens LA (2017) A STING agonist given with OX40 receptor and PD-L1 modulators primes immunity and reduces tumor growth in tolerized mice. Cancer Immunol Res 5(6):468\u2013479. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0284","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"4_CR43","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.nano.2013.01.002","volume":"9","author":"T D\u00e9moulins","year":"2013","unstructured":"D\u00e9moulins T, Bassi I, Thomann-Harwood L, Jandus C, Kaeuper P, Simon HU, von Gunten S, McCullough KC (2013) Alginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cells. Nanomedicine 9(6):806\u2013817. https:\/\/doi.org\/10.1016\/j.nano.2013.01.002","journal-title":"Nanomedicine"},{"issue":"8","key":"4_CR44","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.nano.2014.06.003","volume":"10","author":"T D\u00e9moulins","year":"2014","unstructured":"D\u00e9moulins T, Milona P, McCullough KC (2014) Alginate-coated chitosan nanogels differentially modulate class-A and class-B CpG-ODN targeting of dendritic cells and intracellular delivery. Nanomedicine 10(8):1739\u20131749. https:\/\/doi.org\/10.1016\/j.nano.2014.06.003","journal-title":"Nanomedicine"},{"issue":"8","key":"4_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043248","volume":"7","author":"R Sharma","year":"2012","unstructured":"Sharma R, Ghasparian A, Robinson JA, McCullough KC (2012) Synthetic virus-like particles target dendritic cell lipid rafts for rapid endocytosis primarily but not exclusively by macropinocytosis. PLoS One 7(8):e43248. https:\/\/doi.org\/10.1371\/journal.pone.0043248","journal-title":"PLoS One"},{"issue":"2","key":"4_CR46","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1128\/JVI.00742-11","volume":"86","author":"M Liniger","year":"2012","unstructured":"Liniger M, Summerfield A, Zimmer G, McCullough KC, Ruggli N (2012) Chicken cells sense influenza A virus infection through MDA5 and CARDIF signaling involving LGP2. J Virol 86(2):705\u2013717. https:\/\/doi.org\/10.1128\/JVI.00742-11","journal-title":"J Virol"},{"issue":"2","key":"4_CR47","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","volume":"26","author":"AB Vogel","year":"2018","unstructured":"Vogel AB, Lambert L, Kinnear E, Busse D, Erbar S, Reuter KC, Wicke L, Perkovic M, Beissert T, Haas H, Reece ST, Sahin U, Tregoning JS (2018) Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses. Mol Ther 26(2):446\u2013455. https:\/\/doi.org\/10.1016\/j.ymthe.2017.11.017","journal-title":"Mol Ther"},{"issue":"1","key":"4_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029732","volume":"7","author":"DX Johansson","year":"2012","unstructured":"Johansson DX, Ljungberg K, Kakoulidou M, Liljestrom P (2012) Intradermal electroporation of naked replicon RNA elicits strong immune responses. PLoS One 7(1):e29732. https:\/\/doi.org\/10.1371\/journal.pone.0029732","journal-title":"PLoS One"},{"issue":"1","key":"4_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ymthe.2019.09.009","volume":"28","author":"T Beissert","year":"2020","unstructured":"Beissert T, Perkovic M, Vogel A, Erbar S, Walzer KC, Hempel T, Brill S, Haefner E, Becker R, Tureci O, Sahin U (2020) A trans-amplifying RNA vaccine strategy for induction of potent protective immunity. Mol Ther 28(1):119\u2013128. https:\/\/doi.org\/10.1016\/j.ymthe.2019.09.009","journal-title":"Mol Ther"},{"issue":"6","key":"4_CR50","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.ymthe.2021.04.001","volume":"29","author":"R de Alwis","year":"2021","unstructured":"de Alwis R, Gan ES, Chen S, Leong YS, Tan HC, Zhang SL, Yau C, Low JGH, Kalimuddin S, Matsuda D, Allen EC, Hartman P, Park KJ, Alayyoubi M, Bhaskaran H, Dukanovic A, Bao Y, Clemente B, Vega J, Roberts S, Gonzalez JA, Sablad M, Yelin R, Taylor W, Tachikawa K, Parker S, Karmali P, Davis J, Sullivan BM, Sullivan SM, Hughes SG, Chivukula P, Ooi EE (2021) A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice. Mol Ther 29(6):1970\u20131983. https:\/\/doi.org\/10.1016\/j.ymthe.2021.04.001","journal-title":"Mol Ther"},{"issue":"1\u20132","key":"4_CR51","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0022-1759(03)00273-4","volume":"280","author":"A Summerfield","year":"2003","unstructured":"Summerfield A, Horn MP, Lozano G, Carrasco CP, Atze K, McCullough K (2003) C-kit positive porcine bone marrow progenitor cells identified and enriched using recombinant stem cell factor. J Immunol Methods 280(1\u20132):113\u2013123","journal-title":"J Immunol Methods"},{"issue":"2","key":"4_CR52","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1046\/j.1365-2567.2001.01299.x","volume":"104","author":"CP Carrasco","year":"2001","unstructured":"Carrasco CP, Rigden RC, Schaffner R, Gerber H, Neuhaus V, Inumaru S, Takamatsu H, Bertoni G, McCullough KC, Summerfield A (2001) Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties. Immunology 104(2):175\u2013184","journal-title":"Immunology"},{"key":"4_CR53","doi-asserted-by":"publisher","unstructured":"D\u00e9moulins T, Schulze K, Ebensen T, Techakriengkrai N, Nedumpun T, Englezou PC, Gerber M, Hlushchuk R, Toledo D, Djonov V, von Gunten S, McCullough KC, Liniger M, Guzm\u00e1n CA, Suradhat S, Ruggli N (2023) Coatsome-replicon vehicles: Self-replicating RNA vaccines against infectious diseases. Nanomed 49:102655. https:\/\/doi.org\/10.1016\/j.nano.2023.102655","DOI":"10.1016\/j.nano.2023.102655"}],"container-title":["Methods in Molecular Biology","RNA Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3770-8_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T09:51:17Z","timestamp":1717062677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3770-8_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071637692","9781071637708"],"references-count":53,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3770-8_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"31 May 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}